NCT06254911 2026-01-27
Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Emory University
Phase 2 Suspended
Clinical Trials
5 trialsNCT02784288 2023-06-27
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT01590355 2023-03-08
ORATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Unknown
NCT05025813 2022-08-01
DESQUAMATE
Queensland Health
Phase 2 Recruiting
NCT04220749 2020-09-04
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Recruiting